AstraZeneca to invest £11bn in China after rowing back on UK expansion
Move comes after Britain’s biggest drugmaker’s dispute with government over drug pricingBritain’s biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during Keir Starmer’s visit to the country, just months after cooling on plans for expansion in the UK.The...
<p>Move comes after Britain’s biggest drugmaker’s dispute with government over drug pricing</p><p>Britain’s biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during <a href="https://www.theguardian.com/politics/2026/jan/29/keir-starmer-opens-door-to-uk-visit-by-xi-jinping-after-bilateral-talks">Keir Starmer’s visit to the country</a>, just months after cooling on plans for expansion in the UK.</p><p>The Cambridge-based company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China, where it already has a big presence. It includes the construction of a $2.5bn new research hub in Beijing, which was announced last March.</p> <a href="https://www.theguardian.com/business/2026/jan/29/astrazeneca-invest-11bn-in-china-after-rowing-back-uk-expansion">Continue reading...</a>
Read the full article at:
The Guardian World →